Contact
searchSearch
HMP Global
Login

Advertisement

ADVERTISEMENT

News

News
Rural Patients With PTSD, Bipolar Disorder Engage Well in Telehealth Approaches
03/01/2022
A study looking at 2 models of telehealth found that both approaches offer an opportunity to treat patients with complex psychiatric conditions who otherwise have limited access to specialists.
A study looking at 2 models of telehealth found that both approaches offer an opportunity to treat patients with complex psychiatric conditions who otherwise have limited access to specialists.
A study looking at 2 models of...
03/01/2022
Behavioral Healthcare Executive

Advertisement

News
Structural MRI Shows Only Modest Brain Measure Differences in Children With ADHD
03/01/2022
Children ages 9 and 10 with ADHD differed only modestly from peers without ADHD on structural magnetic resonance imaging (MRI) brain measures, according to study findings.
Children ages 9 and 10 with ADHD differed only modestly from peers without ADHD on structural magnetic resonance imaging (MRI) brain measures, according to study findings.
Children ages 9 and 10 with ADHD...
03/01/2022
Psych Congress Network
News
Zuranolone Co-Initiated With Antidepressant Rapidly Drops Depressive Symptoms
03/01/2022
When co-initiated with an antidepressant, the investigational drug zuranolone significantly reduced depressive symptoms in patients with MDD within 3 days compared with placebo, Sage and Biogen announced.
When co-initiated with an antidepressant, the investigational drug zuranolone significantly reduced depressive symptoms in patients with MDD within 3 days compared with placebo, Sage and Biogen announced.
When co-initiated with an...
03/01/2022
Psych Congress Network
News
FDA Issues Alert Regarding Risks of Compounded Ketamine Nasal Spray Use
02/28/2022
The US Food and Drug Administration recently issued an alert to healthcare professionals regarding potential risks associated with the use of compounded ketamine nasal spray, which is not FDA-approved and has not been evaluated by the...
The US Food and Drug Administration recently issued an alert to healthcare professionals regarding potential risks associated with the use of compounded ketamine nasal spray, which is not FDA-approved and has not been evaluated by the...
The US Food and Drug...
02/28/2022
Psych Congress Network

Advertisement

News
Interactive Report: Aripiprazole LAI Effective in Treating Schizophrenia in Adolescent
02/24/2022
A 2-injection start regimen of aripiprazole LAI showed good efficacy and tolerability in a 16-year-old adolescent with schizophrenia, according to a recent case report.
A 2-injection start regimen of aripiprazole LAI showed good efficacy and tolerability in a 16-year-old adolescent with schizophrenia, according to a recent case report.
A 2-injection start regimen of...
02/24/2022
Psych Congress Network
News
New Drug Application Submitted for Cariprazine in the Treatment of Major Depressive Disorder
02/23/2022
AbbVie has submitted a new drug application (NDA) for cariprazine (VRAYLAR®) to the US Food and Drug Administration (FDA) for the adjunctive treatment of major depressive disorder (MDD) in patients who are receiving ongoing antidepressant...
AbbVie has submitted a new drug application (NDA) for cariprazine (VRAYLAR®) to the US Food and Drug Administration (FDA) for the adjunctive treatment of major depressive disorder (MDD) in patients who are receiving ongoing antidepressant...
AbbVie has submitted a new drug...
02/23/2022
Psych Congress Network
News
Report Presents Opportunities for Expanding Digital Access to Behavioral Health
02/23/2022
The American Medical Association and Manatt Health have collaborated on a report that presents ways in which stakeholders can expand access to treatment digitally through behavioral and physical care integration.
The American Medical Association and Manatt Health have collaborated on a report that presents ways in which stakeholders can expand access to treatment digitally through behavioral and physical care integration.
The American Medical Association...
02/23/2022
Behavioral Healthcare Executive

Advertisement

News
Computerized Adaptive Test for Suicide Risk Shows Predictive Accuracy 1 Year Out
02/23/2022
Scores on the Computerized Adaptive Test Suicide Scale (CAT-SS) were strongly associated with future suicide-related outcomes in US veterans over 12 months, according to study results published online in PLoS One.
Scores on the Computerized Adaptive Test Suicide Scale (CAT-SS) were strongly associated with future suicide-related outcomes in US veterans over 12 months, according to study results published online in PLoS One.
Scores on the Computerized...
02/23/2022
Psych Congress Network
News
Lynn-Marie Morski and Rosalind Watts, Most Influential Women in Psychedelics
02/22/2022
Sana Symposium Steering Committee Members, Lynn-Marie Morski, MD, JD, and Rosalind Watts, MD, named 2 of the 16 most influential women in the psychedelic space.
Sana Symposium Steering Committee Members, Lynn-Marie Morski, MD, JD, and Rosalind Watts, MD, named 2 of the 16 most influential women in the psychedelic space.
Sana Symposium Steering...
02/22/2022
Psych Congress Network
News
During Pandemic’s First Year, Physician Visits for Mental Health, Substance Use Increased
02/18/2022
Outpatient mental health and substance use visits among physicians increased substantially during the first year of the COVID-19 pandemic, according to a population-level cohort study of physicians in Ontario, Canada. Researchers published...
Outpatient mental health and substance use visits among physicians increased substantially during the first year of the COVID-19 pandemic, according to a population-level cohort study of physicians in Ontario, Canada. Researchers published...
Outpatient mental health and...
02/18/2022
Psych Congress Network

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

andrew and julie
Rapid Refresh
Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics
04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and...
04/11/2024
Psych Congress NP Institute
Amber Hoberg
Rapid Refresh
Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder
04/10/2024
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC,...
04/10/2024
Psych Congress NP Institute
Hoberg and Matthews
Clinical Pearls
Tolerability Testing in Long-Acting Injectable Prescriptions
04/03/2024
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for...
04/03/2024
Psych Congress NP Institute

Advertisement

Advertisement

Sign Up

Psych Congress Network Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use